
Syneos Health SYNH
Quartalsbericht 2023-Q2
hinzugefügt 16.05.2026
Land |
|
IPO-Jahr |
2014 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBALSPB |
Anteile |
103 M |
Marktkapitalisierung |
$ 4.46 B |
EBITDA (LTM) |
$ 728 M |
P/E (LTM) |
- |
P/S (LTM) |
0.82 |
EPS (LTM) |
0.92 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Agilent Technologies
A
|
$ 115.08 | 0.1 % | $ 35 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 134.26 | -2.87 % | $ 6.28 B | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 9.11 | 79.68 % | $ 12.1 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 19.69 | -2.28 % | $ 571 M | Nasdaq Global Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Fulgent Genetics
FLGT
|
$ 17.67 | 3.27 % | $ 544 M | Nasdaq Global Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 21.54 | -0.42 % | $ 1.15 B | Nasdaq Global Market,SPB | ||
|
Guardant Health
GH
|
$ 119.85 | 0.76 % | $ 15 B | Nasdaq Global Select Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.8 | -1.1 % | $ 7.96 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 113.85 | -2.51 % | $ 9.39 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 145.23 | 0.56 % | $ 23.1 B | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Lantheus Holdings
LNTH
|
$ 100.06 | -2.85 % | $ 6.75 B | Nasdaq Global Select Market,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 156.73 | -2.23 % | $ 7.77 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Mettler-Toledo International
MTD
|
$ 1 101.33 | -0.16 % | $ 22.7 B | NYSE,SPB | ||
|
Medpace Holdings
MEDP
|
$ 429.11 | -0.85 % | $ 12.4 B | Nasdaq Global Select Market,SPB | ||
|
NeoGenomics
NEO
|
$ 9.27 | 0.43 % | $ 1.19 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 19.04 | -0.21 % | $ 426 M | Nasdaq Global Select Market | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Natera
NTRA
|
$ 200.91 | -1.12 % | $ 19.8 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 3.85 | 0.79 % | $ 357 M | Nasdaq Global Select Market,SPB | ||
|
Personalis
PSNL
|
$ 8.94 | 5.55 % | $ 798 M | Nasdaq Global Select Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 26.94 | -0.04 % | $ 25.5 B | NYSE | ||
|
Senseonics Holdings
SENS
|
$ 6.43 | 1.42 % | $ 268 M | NYSE American | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Biomerica
BMRA
|
$ 2.47 | -0.8 % | $ 5.67 M | Nasdaq Capital Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 258.45 | -0.57 % | $ 21.5 B | NYSE,SPB | ||
|
Twist Bioscience Corporation
TWST
|
$ 64.87 | 7.1 % | $ 3.88 B | Nasdaq Global Select Market,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 448.18 | -0.02 % | $ 169 B | NYSE,SPB | ||
|
Waters Corporation
WAT
|
$ 338.64 | -1.09 % | $ 20.2 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.65 | 7.49 % | $ 233 M | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 9.14 | 2.7 % | $ 1.98 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 192.88 | -1.19 % | $ 21.4 B | NYSE,SPB |